MergerLinks - Robert Bradway

MajorityAcquisitionPrivateDomestic

target

OTEZLA

bidder

Amgen

£10,900m

45 dealmakers

China

AcquisitionPublicMinority

target

Beigene

bidder

Amgen

£2,096m

29 dealmakers

Germany

MajorityAcquisitionPrivatePrivate EquityCross BorderReverse TakeoverDe-SPAC

target

Immatics Biotechnologies

bidder

Arya Sciences Acquisition Corp

£288m

73 dealmakers

China

MinorityPrivateCross BorderAcquisition

target

Beigene

bidder

Amgen

£1,647m

6 dealmakers

Cross BorderVenture CapitalAcquisitionMinorityPrivatePrivate Equity

target

Senti Biosciences

bidder

8VC

£77m

13 dealmakers

AcquisitionPrivate EquityMajorityDomesticPrivate

target

Novisci

bidder

Norwest Venture Partners

value n/a

9 dealmakers

PublicAcquisitionMajorityDomestic

target

Five Prime Therapeutics

bidder

Amgen

£1,361m

34 dealmakers

Singapore

MinorityCross BorderAcquisitionPrivate EquityVenture CapitalPrivate

target

Hummingbird Bioscience

bidder

Frazier Healthcare Partners

£88m

18 dealmakers

AcquisitionDomesticPrivateMajorityPrivate Equity

target

TENEOBIO

bidder

Amgen

£650m

43 dealmakers

DomesticMajorityPublicAcquisition

target

Chemocentryx

bidder

Amgen

£3,043m

28 dealmakers

Turkey

PrivateMajorityAcquisitionDomestic

target

GENSENTA

bidder

The Eczacibasi Group

£110m

14 dealmakers

Private EquityCross BorderPrivateVenture CapitalAcquisitionMinority

target

Neumora Therapeutics

bidder

Arch Venture Partners

£101m

13 dealmakers

DomesticAcquisitionPublicMajority

target

Horizon Therapeutics

bidder

Amgen

£22,860m

87 dealmakers

AcquisitionMinorityPrivatePrivate EquityVenture CapitalCross Border

target

Generate Biomedicines

bidder

Mirae Asset Financial Group

£218m

17 dealmakers